{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:ispectamab tazide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT02577029: Phase 2 Interventional Terminated Hepatitis B
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04450407: Phase 2 Interventional Completed Type 1 Diabetes Mellitus
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pegsebrenatide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00267527: Phase 2 Interventional Terminated Obesity
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03238781: Phase 2 Interventional Completed Chronic Migraine or Episodic Migraine
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
